What is Blue Water Ventures International Inc?
, through its subsidiary, Psycheceutical Inc.
BWVI · Verdict
Limited reward · moderate risk
BWVI's standout is volatility; profitability and valuation weigh on the picture.
Based on 88% data coverage
BWVI · Verdict
Top decile vs peers
0% return on equity
Below average
Earnings +217.7% CAGR
Model-based scoring. For information only — not financial advice.
, through its subsidiary, Psycheceutical Inc. , focuses on developing pharmaceutical products and technologies for mental health treatments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 110.57K.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.